Patents Examined by David E. Wheeler
  • Patent number: 3935213
    Abstract: 6,7-Dimethoxy-4-amino-2-(4-substituted piperazin-1-yl)-quinazolines and 6,7,8-trimethoxy-4-amino-2-(4-substituted piperazin-1-yl)quinazolines are produced by either: (1) reaction of the appropriate 4,5-dimethoxy substituted or 3,4,5-trimethoxy substituted 2-aminobenzonitrile with certain 1,4-disubstituted piperazines; or (2) reaction of the appropriate 4,5-dimethoxy substituted or 3,4,5-trimethoxy substituted 2-aminobenzamidine with the same 1,4-disubstituted piperazines. The products are known hypotensive agents.
    Type: Grant
    Filed: December 5, 1973
    Date of Patent: January 27, 1976
    Assignee: Pfizer Inc.
    Inventor: Hans-Jurgen E. Hess
  • Patent number: 3933826
    Abstract: Protoberberine derivatives having the general formula: ##SPC1##Wherein R.sub.1 is a lower alkoxy group, i.e. C.sub.1 to C.sub.5 alkoxy; R.sub.2 is a lower alkyl group, i.e. C.sub.1 to C.sub.5 alkyl, pyridyl group, phenyl group substituted by two or three lower alkoxy groups, i.e. C.sub.1 to C.sub.5 alkoxy or a phenylvinyl group substituted by two or three lower alkoxy groups, i.e. C.sub.1 to C.sub.5 alkoxy; having excellent analgesic, vasodilating and hypotensive effects and are prepared from know protoberberines by reaction with carobxylic acids.
    Type: Grant
    Filed: November 20, 1973
    Date of Patent: January 20, 1976
    Assignee: Nippon Chemiphar Co., Ltd.
    Inventor: Tetsuji Kametani
  • Patent number: 3933827
    Abstract: 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazoles of the formula ##SPC1##Wherein R.sub.1 is acyl and R.sub.2 is hydrogen or lower alkyl, are described. The end products actively inhibit the growth of transplantable tumors, and are therefore useful as cytostatic agents.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: January 20, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Arnold Brossi, Robert William Guthrie, Richard Wightman Kierstead
  • Patent number: 3933821
    Abstract: Direct production of 1,9-anthrapyrimidine-2-carboxylic acid-1'-anthraquinonylamide in pigmentary form by reaction of 1,9-anthrapyrimidine-2-carboxylic acid chloride with 1-amino-anthraquinone in a polar water-miscible aprotic solvent. The dye is obtained in a high yield and in a very finely divided and pure form. The isolated reaction product may be used direct as a pigment.
    Type: Grant
    Filed: December 19, 1973
    Date of Patent: January 20, 1976
    Assignee: BASF Aktiengesellschaft
    Inventors: Heinrich Hiller, Wolfgang Jentzsch, Alfred Schuhmacher
  • Patent number: 3932415
    Abstract: A class of pyrylium dyes, having at least one rigidized, nitrogen-containing heterocyclic ring fused thereto is described. The rigidized dyes are useful lasing components in lasing media.
    Type: Grant
    Filed: August 20, 1973
    Date of Patent: January 13, 1976
    Assignee: Eastman Kodak Company
    Inventor: George A. Reynolds
  • Patent number: 3932417
    Abstract: Dimeric indole alkolids-vinblastine, des-N-methyl-vinblastine and vincristine-are purified by extracting leaves of Vinca rosea with acid, neutralizing the acidic solution, extracting the dimeric alkaloids into an aromatic solvent, optionally subjecting the extracted alkaloids to gel exclusion chromatography, precipitating the dimeric alkaloids as sulfate salts and finally separating the dimeric alkaloids by high-pressure chromatography.
    Type: Grant
    Filed: October 24, 1973
    Date of Patent: January 13, 1976
    Assignee: Eli Lilly and Company
    Inventor: William E. Jones
  • Patent number: 3932416
    Abstract: Compounds of the general formula (I): ##SPC1##in which R.sub.1, R.sub.2 and R.sub.3 may be the same or different and each represents a hdyrogen atom, an alkyl group, a nitro group, a halogen atom or a group of the formula --NR.sub.4 R.sub.5 or --OR.sub.4 ; in which the groups R.sub.4 and R.sub.5 may be the same or different and each represent a hydrogen atom, or an alkyl, alkenyl or cycloalkyl group (which alkyl group may optionally be substituted by alkoxy, hydroxy, amino, alkylamino, dialkylamino or aryl groups) or R.sub.4 and R.sub.5 together with the nitrogen atom form a heterocyclic ring which may optionally contain additional hetero atoms, e.g. morpholino or piperazinyl; and R.sub.6 represents a hydrogen atom or an alkyl group.These compounds have biological activity, particularly in inhibiting the release of spasmogenic substances arising as a consequence of antigen-antibody reactions.
    Type: Grant
    Filed: June 21, 1973
    Date of Patent: January 13, 1976
    Assignee: Allen & Hanburys Limited
    Inventors: David Edmund Bays, Mervyn Evan Peel, David Martin Waters, Gwynn Pennant Ellis
  • Patent number: 3931179
    Abstract: Disclosed are N,N'-Bis(4-Quinazolinyl)alkanediamines, e.g., N,N'-Bis(7-chloro-4-quinazolinyl)-1,9-nonanediamine, having pharmacological activity in animals and useful for example, as anti-obesity agents. Said compounds may be prepared by reacting a 4-haloquinazoline with an alkanediamine.
    Type: Grant
    Filed: March 6, 1974
    Date of Patent: January 6, 1976
    Assignee: Sandoz Inc.
    Inventor: William R. J. Simpson
  • Patent number: 3931174
    Abstract: Novel quinoxaline-1,4-dioxides of the formula ##SPC1##Wherein R is hydrogen or methyl;Y is lower alkyl; andn is 0, 1, or 2;Methods for their preparation; and their use as antibacterial agents and agents for promoting growth and improving feed efficiency of animals. Additionally, those compounds wherein n is 0 or 1 serve as intermediates for preparation of compounds wherein n is 1 or 2.
    Type: Grant
    Filed: January 23, 1974
    Date of Patent: January 6, 1976
    Assignee: Pfizer Inc.
    Inventor: James W. McFarland